[Federal Register Volume 90, Number 132 (Monday, July 14, 2025)]
[Notices]
[Pages 31204-31206]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-13102]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-25-0978; Docket No. CDC-2025-0057]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a continuing information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled Emerging Infections Program (EIP). The EIP is a population-based
surveillance program that collects data via active, laboratory case
findings and is used for detecting, identifying, and monitoring
emerging pathogens.
DATES: CDC must receive written comments on or before September 12,
2025.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2025-
0057 by either of the following methods:
Federal eRulemaking Portal: www.regulations.gov. Follow
the instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to www.regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (www.regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road, NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Emerging Infections Program (OMB Control No. 0920-0978, Exp. 9/30/
2027)--Revision--National Center for Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The Emerging Infections Programs (EIPs) are population-based
centers of excellence established through a network of state health
departments collaborating with academic institutions; local health
departments; public health and clinical laboratories; infection control
professionals; and healthcare providers. EIPs assist in local, state,
and national efforts to prevent, control, and monitor the public health
impact of infectious diseases.
Activities of the EIPs fall into the following general categories:
(1) active surveillance; (2) applied public health epidemiologic and
laboratory activities; (3) implementation and evaluation of pilot
prevention/intervention projects; and (4) flexible response to public
health emergencies. Activities of the EIPs are designed to: (1) address
issues that the EIP network is particularly suited to investigate; (2)
maintain sufficient flexibility for emergency response and new problems
as they arise; (3) develop and evaluate public health interventions to
inform public health policy and treatment guidelines; (4) incorporate
training as a key function; and (5) prioritize projects that lead
directly to the prevention of disease.
A Revision is being submitted to make existing collection
instruments clearer, consolidate forms and to add new forms. These
forms will allow the EIP to better detect, identify, track changes in
laboratory testing methodology, gather information about laboratory
utilization in the EIP catchment area to ensure that all cases are
being captured, and survey EIP staff to evaluate program quality.
CDC requests OMB approval for an estimated 40,731 burden hours.
There is no cost to respondents other than their time to participate.
[[Page 31205]]
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Avg. burden
Number of Number of per Total
Type of respondent Form No. Form name respondents responses per response burden (in
respondent (in hours) hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
State Health Department................. ABC.100.1 ABCs Case Report Form..... 10 984 20/60 3278
ABC.100.2 ABCs Invasive Pneumococcal 10 127 10/60 212
Disease in Children and
Adults Case Report Form.
ABC.100.5 ABCs Neonatal Infection 10 37 20/60 123
Expanded Tracking Form.
FN.200.1 FoodNet Campylobacter..... 10 550 21/60 1925
FN.200.2 FoodNet Cyclospora........ 10 42 10/60 70
FN.200.3 FoodNet Listeria 10 16 20/60 53
monocytogenes.
FN.200.4 FoodNet Salmonella........ 10 855 21/60 2,993
FN.200.5 FoodNet Shiga toxin 10 290 20/60 967
producing E. coli.
FN.200.6 FoodNet Shigella.......... 10 234 10/60 390
FN.200.7 FoodNet Vibrio............ 10 46 10/60 77
FN.200.8 FoodNet Yersinia.......... 10 55 10/60 92
FN.200.9 FoodNet Hemolytic Uremic 10 10 1 100
Syndrome.
FN.200.10 FoodNet Clinical 10 70 10/60 117
Laboratory Practices and
Testing Volume.
FSN.300.1 FluSurv-Net Influenza 15 576 25/60 3,600
Hospitalization
Surveillance Network Case
Report Form.
FSN.300.2 FluSurv-Net Influenza 13 16 10/60 34
Hospitalization
Surveillance Project
Vaccination Phone Script
and Consent Form (English/
Spanish).
FSN.300.3 FluSurv-Net Influenza 13 126 5/60 136
Hospitalization
Surveillance Project
Provider Vaccination
History Fax Form
(Children/Adults) and
notification letter.
FSN.300.4 FluSurv-NET Laboratory 15 16 10/60 40
Survey.
HAIC.400.1 HAIC-Multi-site Gram- 11 1,581 29/60 8406
Negative Surveillance
Initiative (MuGSI) Case
Report Form (CRF).
HAIC.400.2 HAIC MuGSI CA CP-CRE 10 10 30/60 50
Health interview.
HAIC.400.3 HAIC MuGSI Supplemental 11 1 20/60 4
Surveillance Officer
Survey.
HAIC.400.4 HAIC-Invasive 10 788 29/60 3,809
Staphylococcus aureus
Infection Case Report
Form.
HAIC.400.5 HAIC-Invasive 10 11 9/60 17
Staphylococcus aureus
Laboratory Survey.
HAIC.400.6 HAIC-Invasive 10 1 11/60 2
Staphylococcus aureus
Supplemental Surveillance
Officers Survey.
HAIC.400.7 HAIC-CDI Case Report and 10 1,650 38/60 10,450
Treatment Form.
HAIC.400.8 HAIC-Annual Survey of 10 16 17/60 45
Laboratory Testing
Practices for C.
difficile Infections.
HAIC.400.9 HAIC-CDI Annual 10 1 15/60 3
Surveillance Officers
Survey.
HAIC.400.10 HAIC-Emerging Infections 10 45 5/60 38
Program C. difficile
Surveillance Nursing Home
Telephone Survey (LTCF).
HAIC.400.11 HAIC Candidemia Case 10 170 40/60 1,133
Report Form.
HAIC.400.12 HAIC-Laboratory Testing 10 20 14/60 47
Practices for Candidemia
Questionnaire.
HAIC.400.13 HAIC Death Ascertainment 10 8 24 1,920
Project.
HAIC.400.14 HAIC MuGSI KPC and NDM 10 60 60/60 600
treatment collection form.
--------------------------------------------------------------------------------------------------------------------------------------------------------
Total........................................................................................ ........... .............. ........... 40,731
--------------------------------------------------------------------------------------------------------------------------------------------------------
[[Page 31206]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2025-13102 Filed 7-11-25; 8:45 am]
BILLING CODE 4163-18-P